Marburg Virus Medical Countermeasures
- PMID: 39585611
- DOI: 10.1007/978-1-0716-4256-6_2
Marburg Virus Medical Countermeasures
Abstract
Among the Filoviridae, Marburg virus (MARV) is a biological threat for which no licensed vaccines or therapeutics are currently available. In contrast, we have licensed products for Ebola virus (EBOV), another member of the Filoviridae family. The availability of licensed medical countermeasures (MCMs) for EBOV provides an opportunity to test a key objective of many pandemic preparedness plans, which is to apply some of the same technological approaches demonstrated to be successful for one agent, EBOV, to a second agent, MARV. This chapter will discuss (1) lessons learned from EBOV outbreak responses and MCM development that are applicable to MARV MCM development, (2) the likely concept of operations for using vaccines and therapeutics against MARV, and (3) target product profiles based on the concept of operations. Finally, we will discuss the current status of the MCM pipeline for MARV and next steps to advance these countermeasures to licensure.
Keywords: Antibodies; Clinical trials; Filovirus; MARV; Therapeutic; Vaccine.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Ebola and Marburg virus vaccines.Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26. Virus Genes. 2017. PMID: 28447193 Free PMC article. Review.
-
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.Front Immunol. 2021 Aug 18;12:703986. doi: 10.3389/fimmu.2021.703986. eCollection 2021. Front Immunol. 2021. PMID: 34484200 Free PMC article.
-
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.PLoS One. 2018 Feb 20;13(2):e0192312. doi: 10.1371/journal.pone.0192312. eCollection 2018. PLoS One. 2018. PMID: 29462200 Free PMC article.
-
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22. J Virol. 2009. PMID: 19386702 Free PMC article.
-
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.Hum Vaccin Immunother. 2019;15(10):2359-2377. doi: 10.1080/21645515.2019.1651140. Epub 2019 Oct 7. Hum Vaccin Immunother. 2019. PMID: 31589088 Free PMC article. Review.
References
-
- CDC (2023) Marburg virus disease outbreaks. 2023 [cited 2023 8/22/2023]. Available from: https://www.cdc.gov/vhf/marburg/outbreaks/chronology.html
-
- Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M et al (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 389:P505–P518 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources